NM_001374353.1:c.3035C>T
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4
The NM_001374353.1(GLI2):c.3035C>T(p.Pro1012Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00000376 in 1,595,596 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001374353.1 missense
Scores
Clinical Significance
Conservation
Publications
- holoprosencephaly 9Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Illumina, Ambry Genetics
- combined pituitary hormone deficiencies, genetic formInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- holoprosencephalyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001374353.1. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GLI2 | NM_001374353.1 | MANE Select | c.3035C>T | p.Pro1012Leu | missense | Exon 14 of 14 | NP_001361282.1 | ||
| GLI2 | NM_001371271.1 | c.3086C>T | p.Pro1029Leu | missense | Exon 14 of 14 | NP_001358200.1 | |||
| GLI2 | NM_005270.5 | c.3086C>T | p.Pro1029Leu | missense | Exon 14 of 14 | NP_005261.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GLI2 | ENST00000361492.9 | TSL:1 MANE Select | c.3035C>T | p.Pro1012Leu | missense | Exon 14 of 14 | ENSP00000354586.5 | ||
| GLI2 | ENST00000452319.6 | TSL:5 | c.3086C>T | p.Pro1029Leu | missense | Exon 13 of 13 | ENSP00000390436.1 | ||
| GLI2 | ENST00000341310.10 | TSL:2 | n.*2134C>T | non_coding_transcript_exon | Exon 10 of 10 | ENSP00000344473.6 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152152Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000234 AC: 5AN: 213272 AF XY: 0.0000168 show subpopulations
GnomAD4 exome AF: 0.00000346 AC: 5AN: 1443444Hom.: 0 Cov.: 30 AF XY: 0.00000279 AC XY: 2AN XY: 717478 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152152Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74326 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
Inborn genetic diseases Uncertain:1
The c.3086C>T (p.P1029L) alteration is located in exon 13 (coding exon 13) of the GLI2 gene. This alteration results from a C to T substitution at nucleotide position 3086, causing the proline (P) at amino acid position 1029 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at